Inogen, Inc.INGNNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank21
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P21
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM-1.18%+81.6%
2024-6.41%+65.3%
2023-18.48%-628.7%
2022-2.54%-129.4%
20218.62%+305.7%
20202.13%-77.1%
20199.29%-32.4%
201813.74%-14.1%
201715.99%-10.9%
201617.96%-